Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54,403,891
-
Total 13F shares
-
17,279,112
-
Share change
-
+17,279,112
-
Total reported value
-
$310,677,000
-
Price per share
-
$17.98
-
Number of holders
-
31
-
Value change
-
+$310,677,000
-
Number of buys
-
31
Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q3 2021
As of 30 Sep 2021,
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,279,112 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., SAMLYN CAPITAL, LLC, Woodline Partners LP, BlackRock Inc., Monashee Investment Management LLC, Tudor Investment Corp Et Al, JPMORGAN CHASE & CO, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, and Hudson Bay Capital Management LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.